Nutex Health Inc Overview
Industry: Health Information Services
Sector: Healthcare
Nutex Health Inc. operates as a network of micro-hospitals. It operates through three segments: Hospital, Population Health Management, and Real Estate. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. The Population Health Management segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment leases land and hospital building. It also provides healthcare and facility management services; and healthcare billing, coding, and collection services. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas. Nutex Health Inc. operates as a network of micro-hospitals. It operates through three segments: Hospital, Population Health Management, and Real Estate. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 Read MoreMavefund brings filings, fundamentals, valuation, price history and news for Nutex Health Inc into one research view. The sections below show what strengthens or weakens the research case.
Score
Reported Results
What the company reported, with filing details kept small.
Quarterly result summary
Revenue was $427.2M (reported); EPS was $9.38 (reported).
What changed
- Revenue reported to $427.2M; EPS reported to $9.38.
- Operating income +261% YoY to $121.7M.
- Net income +497% YoY to $96.3M.
Guidance / outlook
No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Other recent earnings materials
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
Nutex Health: A 'Strong Buy' Amid Margin Expansion, Regulatory Tailwinds (Upgrade) (NUTX)
Headline from Seeking Alpha: Nutex Health: A 'Strong Buy' Amid Margin Expansion, Regulatory Tailwinds (Upgrade) (NUTX).
Nutex Health jumps 21%, continuing post-earnings run (NUTX:NASDAQ)
Headline from Seeking Alpha: Nutex Health jumps 21%, continuing post-earnings run (NUTX:NASDAQ).
Earnings call transcript: Nutex Health tops Q2 2026 profit estimates
Headline from Investing.com: Earnings call transcript: Nutex Health tops Q2 2026 profit estimates.
Nutex Health Q2 Earnings Call Highlights
Headline from Yahoo Finance: Nutex Health Q2 Earnings Call Highlights.
Nutex Health, Inc. Q2 2026 Earnings Call Summary
Headline from Yahoo Finance: Nutex Health, Inc. Q2 2026 Earnings Call Summary.
Nutex Health earnings beat by $4.50, revenue fell short of estimates
Headline from Investing.com: Nutex Health earnings beat by $4.50, revenue fell short of estimates.
Earnings Per Share
Return on Equity
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
Metric chart temporarily unavailable.
Net Margin
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Metric chart temporarily unavailable.
Leverage
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Metric chart temporarily unavailable.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.